#immunocompromised — Wednesday, February 04, 2026 (1 items)
| 0 | 💬 0 |
Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-04 | #infection #covid-19 #clinical trial #antiviral #immunocompromised |